In a remarkable achievement, the Global Heterozygous Familial Hypercholesterolemia (HEFH) Management Industry is poised to reach new heights, projecting a valuation of US$ 15.11 billion in fiscal year 2023, a significant increase from US$ 13.2 billion in fiscal year 2022. The market’s upward trajectory is further substantiated by a forecasted consistent compound annual growth rate …
Category Archives: Healthcare Trends
Global Sports Medicine Industry is on a trajectory toward reaching US$ 2,062.7 Million by 2033, Driven Notably by Mental Wellness Initiatives | FMI
The global sports medicine industry size is anticipated to reach a valuation of US$ 1,157.0 million in 2023, driven by focus on mental health in sports. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 6.0% between 2023 and 2033, and reaching a total valuation of approximately …
Global Downstream Processing Industry is projected to witness an 11.3% CAGR surge by 2032, as per FMI Insight’s analysis
As per recent market analysis, the global downstream processing industry demand is set to witness an impressive growth trajectory, estimated to reach a substantial value of US$ 72.3 billion by the end of 2032. This growth is projected at a Compound Annual Growth Rate (CAGR) of 11.3% from 2022 to 2032, marking a significant leap …
Global Pharmaceutical Filtration Industry Projected to Reach US$ 45.08 Billion by 2033 reaching an 8.9% CAGR | FMI
The global pharmaceutical filtration industry demand is poised for significant growth, projected to reach a valuation of US$ 45.08 billion by 2033, according to recent industry analysis. As of 2023, the market stands at US$ 19.19 billion and is anticipated to witness remarkable expansion at a Compound Annual Growth Rate (CAGR) of 8.9% from 2023 …
Global Molecular Imaging Industry is projected to achieve a value of US$ 15,457.48 Million by the year 2033, with an 11% CAGR | according to FMI
According to forecasts, the global molecular imaging industry size is expected to be US$ 5,437.16 million in 2023 and US$ 15,457.48 million by 2033. The market is projected to exhibit a CAGR of 11%. The need for early illness diagnosis is increasing due to the rising incidence of numerous chronic diseases like cancer and other …
Global Multiplex Biomarker Imaging Market Set to Surge at 11.9% CAGR, Driven by Cancer Growth and Personalized Medicine | FMI
The global multiplex biomarker imaging market is poised for explosive growth, reaching an estimated US$ 1,041.7 Million by 2029, according to a recent survey by Future Market Insights (FMI). This represents a significant leap from the US$ 475.2 Million in 2022, translating to a robust 11.9% CAGR. To Remain Ahead of Your Competitors, Request For …
Global Dermal Fillers and Botulinum Toxin Market Projected to Reach US$ 10.5 Billion by 2032, Reports Industry Analysis
The market for dermal fillers and botulinum toxins is on a trajectory for massive expansion, reaching a projected US$ 10.5 billion by 2032, according to industry experts. This represents a significant jump from the market’s US$ 5.9 billion valuation at the end of 2022 and signifies a robust CAGR of 6.1% over the next decade. …
Global Diabetic Macular Edema Market Poised for Steady Growth US$ 4.2 Billion by 2032: Despite Challenges, Driven by Rising Diabetes Rates | FMI
The global diabetic macular edema (DME) market is expected to reach a valuation of US$ 3.7 billion by the end of 2022, with a projected CAGR of 1.2% from 2022 to 2032, reaching a valuation of ~US$ 4.2 billion by the end of the forecast period, according to market research firm FMI. Despite a modest …
Global Farm Animal Pharmaceutical Industry Projected to Reach US$ 29.4 Billion by 2032: FMI
The global farm animal pharmaceutical industry is poised for substantial growth, with projections indicating a significant increase in market size by the end of the decade. According to recent forecasts, the global farm animal pharmaceutical industry is expected to reach a value of US$ 17.2 billion by the close of 2022, with a compound annual …
Global Oral Controlled Release Drug Delivery Technology Industry to climb to an impressive US$ 68.4 Billion by 2032 | FMI
The global oral controlled release drug delivery technology industry is projected to witness a significant surge, growing from US$ 34.1 billion in 2022 to a staggering US$ 68.4 billion by 2032, according to a recent market analysis. This remarkable expansion translates to a robust 7.2% compound annual growth rate (CAGR) over the forecast period. The …